Treatment preferences of patients receiving opioid agonist therapy in spain: a discrete choice experiment.

ABSTRACT:

Aim

To explore the preferences of patients with opioid use disorder (OUD) regarding opioid agonist treatment (OAT).

Methods

The present study was a descriptive, observational, cross-sectional study in OUD patients on treatment for at least 3 months, using one of the pharmacological options available in Spain: methadone (MTD) tablets, MTD oral solution, sublingual buprenorphine/naloxone (SL BPN/NX) or long-acting injectable buprenorphine (LAIB). A discrete choice experiment (DCE) assessed which medication attributes patients prioritized when selecting a hypothetical ideal treatment for their disease.

Results

128 patients from 10 different addiction centres (AC) participated in this study. Treatment groups were balanced: liquid MTD: 28.1%; LAIB: 25%; SL BPN/NX: 24.2%, a

SUBMITTER: Dorado Garcia ML 

PROVIDER: S-EPMC12933860 | biostudies-literature | 2026 Jun

REPOSITORIES: biostudies-literature